Life at Deloitte
Consultant, Strategy & Operations
Natasha is a Consultant in Deloitte’s Strategy and Operations - Business Model Transformation team. She has worked on transformation projects for a variety of clients but for the last two-and-a-half years, Natasha has focused on process design/improvement within the Life Sciences and Health Care (LSHC) sector.
Natasha is an outstanding contributor to the LSHC team, where she has supported the implementation of EU legislation and advised pharmaceutical organisations on patient safety and patient access to life-saving medicine. Her ability to support clients with ethical and organisational challenges goes far beyond a typical consulting role.
Natasha’s work includes:
European Medicines Agency - Pharmacovigilance Fees Regulation:
Natasha supported the roll-out of new pharmacovigilance (drug safety) EU legislation. She took the project from the requirements gathering phase through process design and development to testing and implementation of process and system changes. The project has enabled the EMA to collect over €30 million in annual revenues which will help fund patient safety initiatives across Europe.
Top 10 Pharmaceutical Company - Post-Trial Access:
Natasha supported a Top 10 Pharmaceutical Company in the development of a process to ensure continuing provision of medicine to patients with life-threatening or severe medical conditions following their participation in clinical trials. Her work will help the company extend patient lives, or improve their quality of life whilst also fulfilling the company’s ethical obligations to its patients. She has subsequently supported the global roll out of the process to around 60 affiliates, including developing training packs and associated communications.